Similar articles

• Selective antagonism of prostaglandin (PG) E1, PGD2 and prostacyclin (PGI2) on human and rabbit platelets by di-4-phloretin phosphate (DPP).

  Westwick J, Webb H. Westwick J, et al. Thromb Res. 1978 Jun;12(6):973-8. doi: 10.1016/0049-3848(78)90053-1. Thromb Res. 1978. PMID: 358484 No abstract available.
• Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.

  Whittle BJ, Moncada S, Vane JR. Whittle BJ, et al. Prostaglandins. 1978 Sep;16(3):373-88. doi: 10.1016/0090-6980(78)90216-2. Prostaglandins. 1978. PMID: 364545
• Prostaglandins as inhibitors of human platelet aggregation.

  Di Minno G, Silver MJ, de Gaetano G. Di Minno G, et al. Br J Haematol. 1979 Dec;43(4):637-47. doi: 10.1111/j.1365-2141.1979.tb03797.x. Br J Haematol. 1979. PMID: 393296
• Pharmacology of platelet-suppressive agents.

  Wautier JL, Caen JP. Wautier JL, et al. Semin Thromb Hemost. 1979 Spring;5(4):293-315. doi: 10.1055/s-0028-1087160. Semin Thromb Hemost. 1979. PMID: 386519 Review. No abstract available.
• Antiplatelet agents: rationale and results.

  Kelton JG. Kelton JG. Clin Haematol. 1983 Feb;12(1):311-54. Clin Haematol. 1983. PMID: 6132693 Review. No abstract available.